First-in-Human Study of ICT01 in Patients With Advanced Cancer
Clinical trial NCT04243499 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04243499
- Sponsor
- ImCheck Therapeutics, an Ipsen company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2027-10-01
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.